Ciertos problemas de salud y efectos secundarios pueden impedir el uso seguro del medicamento
A food-effect study carried out in healthy volunteers ( N = 78) reported that individuals receiving once-daily oral semaglutide in the fasting state ( n = 26) had measurable exposure, whereas this was not the case in the fed state where exposure was either limited (11 of 25 individuals) or not observed (14 out of 25 individuals) [25, 28]
Case 3 In 1983, a 59-year-old male was diagnosed with IgA nephropathy
The triple interactions between gut microbiota, mycobiota and host immunity
Food and Drug Administration (2025) Tirzepatide, StatPearls [Internet] (2024) Adverse events related to tirzepatide, Journal of the Endocrine Society (2023) Tirzepatide-induced gastrointestinal manifestations: A systematic review and meta-analysis, Cureus (2023) Gastrointestinal adverse events of tirzepatide in the treatment of Type 2 diabetes mellitus: A meta-analysis and trials sequential analysis, Medicine (2023) Glucagon-like peptide-1 receptor agonists, StatPearls [Internet] (2024) How may GIP enhance the therapeutic efficacy of GLP-1?, Trends in Endocrinology & Metabolism (2020) Comparative efficacy of tirzepatide vs
Your provider will evaluate whether continuing escalation or maintaining current dose best supports your health and treatment goals